Wolfgang Miesbach: A Mim8 Extension Study by Pratima Chowdary’s Team Showing Robust Profile in Hemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Promising Long-term Safety Data: Mim8 Extension Study Demonstrates Robust Profile in Hemophilia A.
Great results from the FRONTIER1 Phase 1/2 Multiple Ascending Dose (MAD) extension study show exceptional long-term safety for Mim8 (denecimig) across 69.5 patient-years of exposure in 41 patients with severe hemophilia A.
Study Design and Population:
Phase 1/2 extension study (up to 148 weeks additional treatment)
Mean age: 33.1 years (range 14-64), including 6 adolescents
90.2% without inhibitors, 9.8% with inhibitors
Outstanding Safety Profile:
Exceptional injection tolerability: Only 0.2% injection-site reaction rate (6 reactions in 3,128 injections)
Zero anti-Mim8 antibodies detected throughout extension
No thromboembolic events observed
Only 2 patients discontinued:
– 1 due to Hodgkin lymphoma (unrelated to Mim8)
– 1 due to patient decision after sequence of joint bleeds
85.4% experienced mostly mild-moderate TEAEs (unrelated to treatment)
Clinical Efficacy:
67.7% of patients on weekly dosing achieved zero bleeds
88.9% of patients on monthly dosing achieved zero bleeds
Flexible dosing options: QW (6-11mg) OR Q4W (30-46mg)
Stable thrombin generation within target range (150-200 nM)
Superior Potency Confirmed:
Mim8 achieved comparable peak thrombin generation at approximately 15-fold lower plasma concentrations than emicizumab.
This refers to the actual drug concentration needed in blood plasma to achieve similar haemostatic effect.
Next Steps:
These compelling extension data support the ongoing Phase 3 FRONTIER2 (NCT05053139) and FRONTIER3 (NCT05306418) trials, plus the planned FRONTIER4 long-term study investigating biweekly dosing options.
Congratulations to Pratima Chowdary and the international research team on these results published in RPTH Journal.”
Read the full article in RPTH.
Article: FRONTIER1 multiple ascending dose extension: a safety, tolerability, pharmacokinetics, and pharmacodynamics study of Mim8 in patients with haemophilia A
Authors: Pratima Chowdary, Steven R. Lentz, Lidia Gil, Francisco J. López-Jaime, Jerzy Windyga, Wan Hui Ong Clausen, Peter Nørkjær Laursen, Johnny Mahlangu
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Oct 15, 2025, 06:01Nita Radhakrishnan Presented The Collaborative Data on Hemophilia from Indian Centers at MENA Conference 2025
-
Oct 15, 2025, 05:53Chris Miskel Shared An Exciting Sneak Peek of The VBRI expansion at The Versiti Vision Summit
-
Oct 14, 2025, 06:19Kay Sharma: I Feel Incredibly Proud and Honored to Share the Final Agenda for The ISTH Continuing Education Forum
-
Oct 14, 2025, 06:12Murray Adams: Professor Favaloro Presented Talks On The 100-Year History of von Willebrand Disease
-
Oct 14, 2025, 06:10Samuel Nweke on Significance of MPV in a CBC in Diagnosis
-
Oct 15, 2025, 06:02Ming Y Lim on Building A Foundation for Women and Girls With Blood Disorders Clinic of Excellence Model
-
Oct 15, 2025, 05:56Wolfgang Miesbach: A Mim8 Extension Study by Pratima Chowdary's Team Showing Robust Profile in Hemophilia A
-
Oct 15, 2025, 05:52Michael Hadley: A Sober Reminder that Ischemic Heart Disease Remains the #1 Cause of Death Worldwide
-
Oct 14, 2025, 06:13Amaliris Guerra: Driving True Innovation in Preclinical Drug Development Related to Iron-Metabolism and Inflammation is One of My Passions!
-
Oct 14, 2025, 05:30Patrick Hsu: A New DNA Editing Technology Reported In Science Magazine
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 13, 2025, 04:48Archil Jaliashvili showcases how BHOC builds on Hemopure’s success to revolutionize surgery and care
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 15, 2025, 05:59Courtney Lawrence: I've Got A Place at American Red Cross for You!
-
Oct 15, 2025, 05:50Patrick Robert Receives Otto Schwarz Award at Plasma Protein Forum 2025
-
Oct 15, 2025, 05:48Bravo Awards 2025 Nominees - For Contributions in Caring For Children With Cancer And Blood Disorders
-
Oct 15, 2025, 05:43Watch ITP Awareness Month Quiz by Rocel C Saputil, Michelle MH Tan and The Team
-
Oct 15, 2025, 01:30ISTH President Pantep Angchaisuksiri's Team Organized A ''Run for Flow'' Event to Mark World Thrombosis Day 2025!